S2 Ep59: Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Pharmacy Focus
30/07/2025 33 min Temporada 2 Episodio 59
S2 Ep59: Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Listen "S2 Ep59: Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC"

Descargar episodio Ver en sitio original

Episode Synopsis

Kevin Chen, PharmD, MS, BCOP, CPP, and Amanda Cass, PharmD, BCPS, BCOP, share key insights about ROS1, non-small cell lung cancer, and the new approved drug taletrectinib.



More episodes of the podcast Pharmacy Focus

S2 Ep67: Pharmacist Takeover: A Day in the Life of an Oncology Pharmacist 24/12/2025
S2 Ep66: Tracking Tumor Evolution Through MRD and ctDNA 28/11/2025
S2 Ep65: Pharmacist Takeover: CGVHD and Axatilimab 24/11/2025
65: Bridging Science and Practice in Acute Migraine Therapy 21/11/2025
S2 Ep64: Pharmacist Takeover: BCMA Bispecifics and CAR T-Cell Therapy 07/10/2025
S2 Ep63: From Policy to Practice: How the ACC Legislative Conference Advances Cardiovascular Care 06/10/2025
S2 Ep62: A Silent Killer: Unmasking Radon’s Link to Lung Cancer 08/09/2025
S2 Ep61: Protecting Community Oncology Practices in the Wake of the IRA 29/08/2025
S2 Ep60: Pharmacy Focus: Role of Pharmacists in Proper Inhaler Usage 25/08/2025
S2 Ep58: Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike 10/07/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA